| |
Company
Roster
|
|
Total
Insiders : |
77 |
|
|
|
Total
Direct Shares :
|
2,250,353 |
|
|
Total
Indirect Shares :
|
1,588,269 |
| |
%
Held by Insiders:
|
1.46% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Singhal Priya |
Head of Development |
2024-04-02 |
4,886 |
|
0 |
| Murphy Nicole |
Head of Pharm Ops and Tech |
2024-04-01 |
9,634 |
|
0 |
| Izzar Rachid |
Head of Global Product Strat. |
2024-02-16 |
9,701 |
2021-12-02 |
0 |
| Alexander Susan H |
EVP Chief Legal Officer |
2024-02-16 |
51,683 |
2007-01-30 |
0 |
| Gregory Ginger |
EVP, Human Resources |
2024-02-16 |
13,584 |
2017-08-01 |
0 |
| Kramer Robin |
Chief Accounting Officer |
2024-02-16 |
6,227 |
2019-12-03 |
0 |
| Mcdonnell Michael R |
EVP, Chief Financial Officer |
2024-02-16 |
19,406 |
2021-09-01 |
0 |
| Rowinsky Eric K |
Director |
2024-02-15 |
20,629 |
2010-03-22 |
0 |
| Langer Susan |
Director |
2023-06-26 |
459 |
2023-06-26 |
0 |
| Hawkins William A |
Director |
2023-06-26 |
5,150 |
2019-06-19 |
0 |
| Sherwin Stephen A |
Director |
2023-06-26 |
18,738 |
2010-03-22 |
0 |
| Freire Maria C |
Director |
2023-06-26 |
3,105 |
2021-07-01 |
0 |
| Mantas Jesus B |
Director |
2023-06-26 |
6,048 |
2019-06-19 |
0 |
| Dorsa Caroline |
Director |
2023-06-26 |
24,822 |
2010-01-04 |
0 |
| Viehbacher Christopher |
Officer, Director |
2022-11-14 |
7,000 |
|
0 |
| Jones William D /ca/ |
Director |
2022-06-15 |
2,145 |
2021-07-01 |
0 |
| Denner Alexander J |
Director |
2022-06-15 |
15,099 |
2022-06-15 |
643,000 |
| Papadopoulos Stelios |
Director |
2022-06-15 |
10,095 |
2022-06-15 |
28,206 |
| Mulligan Richard |
Director |
2022-06-15 |
15,099 |
2009-06-10 |
0 |
| Guindo Chirfi |
Head of Glob Prod Strat & Com |
2022-02-18 |
7,364 |
2017-12-01 |
0 |
| Vounatsos Michel |
Chief Executive Officer, Director |
2022-02-18 |
67,261 |
2017-02-27 |
0 |
| Galdes Alphonse |
EVP Pharmaceutical Oper & Tech |
2022-01-19 |
5,064 |
2022-01-19 |
969 |
| Leaming Nancy |
Director |
2021-07-01 |
13,763 |
2008-01-08 |
0 |
| Posner Brian S |
Director |
2021-07-01 |
8,175 |
2009-06-03 |
0 |
| Sandrock Alfred |
Head of Research & Development |
2021-06-07 |
10,169 |
|
0 |
| Pangia Robert W |
Director |
2020-06-03 |
20,632 |
2004-05-05 |
0 |
| Karp Daniel |
EVP, Corporate Development |
2020-02-12 |
930 |
|
0 |
| Capello Jeffrey D |
EVP & Chief Financial Officer |
2020-02-12 |
3,118 |
2019-01-02 |
0 |
| Schenk Lynn |
Director |
2019-06-19 |
9,032 |
2019-06-19 |
3,100 |
| Ehlers Michael D |
EVP, Research and Development |
2019-06-01 |
8,025 |
2016-06-01 |
0 |
| Mckenzie Paul |
EVP Pharmaceutical Oper & Tech |
2019-03-01 |
7,235 |
|
0 |
| Covino Gregory F |
VP, Chief Accounting Officer |
2018-02-23 |
4,744 |
2013-05-01 |
0 |
| Clancy Paul J |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
| Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
2016-12-01 |
7,360 |
2014-10-01 |
0 |
| Scangos George A |
Chief Executive Officer, Director |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
| Koppel Adam |
EVP, Strategy and Bus. Dev. |
2016-06-06 |
2,402 |
2015-06-02 |
0 |
| Artavanis-Tsakonas Spyridon |
EVP, Chief Scientific Officer |
2016-04-02 |
3,149 |
|
0 |
| Cox John |
EVP Pharmaceutical Oper & Tech |
2016-04-01 |
39,045 |
|
0 |
| Holtzman Steven H |
EVP Corporate Development |
2016-02-23 |
8,326 |
2012-02-01 |
0 |
| Dipietro Kenneth |
EVP Human Resources |
2016-02-23 |
3,937 |
2013-02-01 |
0 |
| Williams Douglas E |
EVP Research & Development |
2015-06-19 |
11,817 |
|
0 |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
2015-02-12 |
8,132 |
2012-02-06 |
0 |
| Young William |
Director |
2014-01-08 |
18,509 |
2004-05-25 |
0 |
| Pawlicki Raymond |
SVP, Chief Information Officer |
2013-11-22 |
8,710 |
|
0 |
| Gagnon Robert E. |
Vice President, Finance |
2012-02-29 |
3,999 |
|
0 |
| Granata Francesco |
EVP Global Commercial Operatio |
2011-07-01 |
0 |
2011-02-01 |
0 |
| Schneier Craig Eric |
EVP, HR, Public Affairs & Comm |
2011-03-02 |
10,201 |
2011-03-02 |
460 |
| Maclean Michael F |
SVP, Chief Accounting Officer |
2010-10-01 |
10,681 |
2007-02-12 |
0 |
| Ross Bruce |
Director |
2010-06-08 |
9,900 |
2003-11-13 |
0 |
| Mullen James C |
CEO & President, Director |
2010-06-08 |
95,503 |
2010-06-08 |
75,000 |
| Hamm Robert A |
Chief Operating Officer |
2010-04-23 |
27,212 |
|
0 |
| Lytton Michael |
EVP Corporate & Business Devel |
2010-03-02 |
18,869 |
|
0 |
| Pickett Cecil B |
President, R & D, Director |
2009-10-02 |
88,732 |
2006-10-02 |
0 |
| Dekkers Marijn E |
Director |
2009-06-03 |
6,595 |
2007-05-31 |
0 |
| Sharp Philip A |
Director |
2009-06-03 |
470,278 |
2003-11-12 |
0 |
| Dunn John Michael |
EVP, New Ventures |
2009-02-24 |
24,752 |
2005-12-22 |
160 |
| Hasler Hans Peter |
Chief Operating Officer |
2009-02-24 |
53,261 |
2007-02-13 |
0 |
| Wiggins Mark C |
EVP Corp and Business Development |
2008-09-26 |
22,780 |
2007-12-31 |
676 |
| Hasnain Faheem |
EVP, Oncology/Rheumatology SBU |
2008-07-09 |
25,454 |
|
0 |
| Best Lawrence C |
Director |
2008-06-19 |
5,600 |
2007-05-25 |
0 |
| Glassberg Alan |
Director |
2008-06-19 |
5,600 |
2003-10-28 |
0 |
| Keller Thomas F |
Director |
2007-10-15 |
2,300 |
2007-10-15 |
1,250 |
| Adelman Burt A |
EVP, Portfolio Strategy |
2007-10-15 |
12,769 |
2007-10-15 |
8,009 |
| Kowolenko Michael |
SVP, Pharm Ops & Technology |
2007-07-25 |
18,123 |
|
0 |
| Good Mary L |
Director |
2007-05-25 |
1,250 |
2004-05-24 |
0 |
| Belzer Alan |
Director |
2007-05-25 |
41,500 |
2007-05-25 |
11,500 |
| Kellogg Peter N |
EVP, Finance and CFO |
2007-03-20 |
18,966 |
2004-02-06 |
0 |
| Matsui Connie |
EVP, Corp. Strategy and Comm. |
2007-02-12 |
22,837 |
2007-02-12 |
40,766 |
| Arner Raymond G |
Officer |
2005-06-16 |
13,142 |
|
0 |
| Cook Anne Marie |
Officer |
2005-03-09 |
9,191 |
|
0 |
| Rastetter William H |
Executive Chairman, Director |
2005-02-23 |
50,676 |
2005-02-23 |
373,929 |
| Bucknum Thomas J |
EVP and General Counsel |
2005-02-18 |
14,750 |
2004-05-04 |
0 |
| Gilman Michael |
EVP - Research |
2004-12-28 |
36,176 |
2004-06-15 |
0 |
| Rohn William R |
Chief Operating Officer |
2004-11-17 |
85,763 |
2004-11-17 |
383,388 |
| Hanna Nabil |
EVP Discovery Research |
2004-04-01 |
450,904 |
2003-03-31 |
0 |
| Gregoire Sylvie L |
EVP, Bus. Dev & Program Mgmt. |
2003-11-12 |
1,304 |
2003-11-12 |
0 |
| Rodriguez Edward |
VP and Controller |
2003-08-29 |
5,284 |
2003-09-02 |
7,100 |
|
1.65 (0.84%) 
